Smithtown, NY, United States of America

Nungavaram S Ramamurthy


Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 470(Granted Patents)


Company Filing History:


Years Active: 1987-2005

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Nungavaram S Ramamurthy: Innovator in Medical Science

Introduction

Nungavaram S Ramamurthy is a distinguished inventor based in Smithtown, NY (US). He has made significant contributions to the field of medical science, particularly in the development of methods to combat cataract formation and cancer growth. With a total of 13 patents to his name, his work has had a profound impact on health and medicine.

Latest Patents

Among his latest patents, Ramamurthy has developed an inhibitor of cataract formation. This invention provides methods for reducing the risk of cataract development in mammals by administering an effective amount of a tetracycline derivative. A preferred derivative mentioned in his patent is 6α-deoxy 5-hydroxy-4-dedimethylaminotetracycline. Additionally, he has created a method of inhibiting cancer growth, specifically targeting sarcomas such as Kaposi's sarcoma. This method employs 6-demethyl-6-deoxy-4-de(dimethylamino)tetracycline (CMT-3).

Career Highlights

Throughout his career, Ramamurthy has worked with notable institutions, including the State University of New York and the Hospital for Joint Diseases. His research and innovations have been pivotal in advancing medical treatments and improving patient outcomes.

Collaborations

Some of his notable coworkers include Lorne M Golub and Thomas F McNamara. Their collaborative efforts have contributed to the success of his inventions and the advancement of medical science.

Conclusion

Nungavaram S Ramamurthy is a remarkable inventor whose work in medical science has led to significant advancements in the treatment of cataracts and cancer. His contributions continue to influence the field and improve the lives of many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…